Evidence map›Paper›PMID 39070149›Full record

ArticleFrontiers in oncology2024

Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer

Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, Jacob J Orme, Brian J Burkett, Ann T Packard, Derek R Johnson, Matthew P Thorpe, Irbaz Bin Riaz, Thorvardur R Halfdanarson and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Advancing patient education in PRRT through large language models: challenges and potential.American journal of nuclear medicine and molecular imaging · 2025
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gokce Belge BilginDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Cem BilginDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Daniel S ChildsDivision of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.
Jacob J OrmeDivision of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.
Brian J BurkettDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Ann T PackardDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Derek R JohnsonDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Matthew P ThorpeDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Irbaz Bin RiazDepartment of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, United States.
Thorvardur R HalfdanarsonDivision of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, United States.
Geoffrey B JohnsonDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Oliver SartorDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Ayse Tuba KendiDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Many patients use artificial intelligence (AI) chatbots as a rapid source of health information. This raises important questions about the reliability and effectiveness of AI chatbots in delivering accurate and understandable information. Purpose: To evaluate and compare the accuracy, conciseness, and readability of responses from OpenAI ChatGPT-4 and Google Bard to patient inquiries concerning the novel Materials and methods: Two experts listed the 12 most commonly asked questions by patients on Results: Eight experts participated in the survey, evaluating 12 AI-generated responses across the three domains of accuracy, conciseness, and readability, resulting in 96 assessments (12 responses x 8 experts) for each domain per chatbot. ChatGPT-4 provided more accurate answers than Bard (2.95 ± 0.671 vs 2.73 ± 0.732, Conclusion: AI chatbots have gained significant attention, and their performance is continuously improving. Nonetheless, these technologies still need further improvements to be considered reliable and credible sources for patients seeking medical information on

Indexed as

177 Lu-PSMA-617 therapyartificial intelligenceBardchatbotChatGPTinformation literacymachine learningprostate cancer

Identifiers

PMID39070149
PMCPMC11272524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.